275 related articles for article (PubMed ID: 22821819)
21. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
22. Heterotopic hindlimb allotransplantation in rats: an alternative model for immunological research in composite-tissue allotransplantation.
Ulusal AE; Ulusal BG; Hung LM; Wei FC
Microsurgery; 2005; 25(5):410-4. PubMed ID: 16037937
[TBL] [Abstract][Full Text] [Related]
23. The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.
Lin CH; Anggelia MR; Cheng HY; Wang AYL; Chuang WY; Lin CH; Lee WPA; Wei FC; Brandacher G
Cell Mol Immunol; 2021 Feb; 18(2):363-373. PubMed ID: 31754236
[TBL] [Abstract][Full Text] [Related]
24. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
[TBL] [Abstract][Full Text] [Related]
25. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
[TBL] [Abstract][Full Text] [Related]
26. Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation.
Xie HY; Huang DS; Jia CK; Zheng SS
J Zhejiang Univ Sci B; 2005 Dec; 6(12):1188-94. PubMed ID: 16358377
[TBL] [Abstract][Full Text] [Related]
27. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
[TBL] [Abstract][Full Text] [Related]
28. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
29. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.
Wachtman GS; Wimmers EG; Gorantla VS; Lin CH; Schneeberger S; Unadkat JV; Zheng XX; Brandacher G; Lee WP
Transplant Proc; 2011 Nov; 43(9):3541-4. PubMed ID: 22099837
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
31. A new method of bone marrow transplantation leads to extension of skin allograft survival.
Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
[TBL] [Abstract][Full Text] [Related]
32. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation.
Siemionow M; Ulusal BG; Ozmen S; Ulusal AE; Ozer K
Microsurgery; 2004; 24(3):200-6. PubMed ID: 15160378
[TBL] [Abstract][Full Text] [Related]
33. An alternative model of vascularized bone marrow transplant: partial femur transplantation.
Chen JW; Chen C; Su YJ; Yan L; Wang SP; Guo SZ
Ann Plast Surg; 2014 Dec; 73(6):710-5. PubMed ID: 24830660
[TBL] [Abstract][Full Text] [Related]
34. Large antigenic skin load in total abdominal wall transplants permits chimerism induction.
Nasir S; Bozkurt M; Klimczak A; Siemionow M
Ann Plast Surg; 2008 Nov; 61(5):572-9. PubMed ID: 18948789
[TBL] [Abstract][Full Text] [Related]
35. Donor T-cell development in host thymus after heterotopic limb transplantation in mice.
Li Z; Benghiat FS; Kubjak C; Schuind F; Goldman M; Le Moine A
Transplantation; 2007 Mar; 83(6):815-8. PubMed ID: 17414717
[TBL] [Abstract][Full Text] [Related]
36. Inducing mixed chimerism and transplantation tolerance through allogeneic bone marrow transplantation with costimulation blockade.
Pree I; Wekerle T
Methods Mol Biol; 2007; 380():391-403. PubMed ID: 17876108
[TBL] [Abstract][Full Text] [Related]
37. Tolerance induction in composite facial allograft transplantation in the rat model.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow M
Plast Reconstr Surg; 2004 Dec; 114(7):1790-801. PubMed ID: 15577350
[TBL] [Abstract][Full Text] [Related]
38. Heterotopic sternum transplant in rats: A new model of a vascularized bone marrow transplantation.
Santiago SF; de Faria W; Khan TF; Gandia CE; Misiakos EP; Ferrer L; Ruiz P; Coleman L; Fernandez HF; Miller J; Ricordi C; Tzakis AG
Microsurgery; 1999; 19(7):330-4. PubMed ID: 10586198
[TBL] [Abstract][Full Text] [Related]
39. Impact of donor bone marrow on survival of composite tissue allografts.
Siemionow M; Nasir S
Ann Plast Surg; 2008 Apr; 60(4):455-62. PubMed ID: 18362579
[TBL] [Abstract][Full Text] [Related]
40. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
